Efectos de la diabetes, la obesidad y otras enfermedades | 07 ABR 14

Pérdida de masa muscular relacionada con la edad y enfermedades

La elevada prevalencia de la pérdida de masa muscular relacionada con la edad y con las enfermedades son grandes factores de riesgo de discapacidad.
Autor/a: Dres. Rita Rastogi Kalyani, Mark Corriere, Luigi Ferrucci doi:10.1016/S2213-8587(14)70034-8
INDICE:  1.  | 2. 

1 Candow DG, Chilibeck PD. Diff erences in size, strength, and power of upper and lower body muscle groups in young and older men. J Gerontol A Biol Sci Med Sci 2005; 60: 148–56.
2 Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in skeletal muscles and their eff ect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol (1985) 2003; 95: 1851–60.
3 Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr 1997; 127 (suppl): 990–91.
4 Thomas DR. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 2007;26: 389–99.
5 Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755–63.
6 Janssen I, Heymsfi eld SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is  associated with functional impairment and physical disability. J Am Geriatr Soc 2002; 50: 889–96.
7 Newman AB, Kupelian V, Visser M, et al, and the Health ABC Study Investigators. Sarcopenia: alternative defi nitions and associations with lower extremity function. J Am Geriatr Soc 2003;51: 1602–09.
8 Clark BC, Manini TM. Sarcopenia/dynapenia. J Gerontol A Biol Sci Med Sci 2008; 63: 829–34.
9 Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al, and the European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on defi nition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412–23.
10 Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus defi nition:prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011; 12: 249–56.
11 von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle 2010; 1: 129–33.
12 Volpato S, Bianchi L, Cherubini A, et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people:application of the EWGSOP defi nition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci 2013; 13 Visser M, Goodpaster BH, Kritchevsky SB, et al. Muscle mass, muscle strength, and muscle fat infi ltration as predictors of incident mobility limit ations in well-functioning older persons. J Gerontol A Biol Sci Med Sci 2005; 60: 324–33.
14 Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 2004; 52: 80–85.
15 Short KR, Vittone JL, Bigelow ML, Proctor DN, Nair KS. Age and aerobic exercise training eff ects on whole body and muscle protein metabolism. Am J Physiol Endocrinol Metab 2004; 286: E92–101.
16 Lexell J. Human aging, muscle mass, and fi ber type composition. J Gerontol A Biol Sci Med Sci 1995; 50: 11–16.
17 Campbell MJ, McComas AJ, Petito F. Physiological changes in ageing muscles. J Neurol Neurosug Psychiatry 1973; 36: 174–82.
18 Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2006; 61: 1059–64.
19 Baum K, Hildebrandt U, Edel K, et al. Comparison of skeletal muscle strength between cardiac patients and age-matched healthy controls. Int J Med Sci 2009; 6: 184–91.
20 Moore AZ, Caturegli G, Metter EJ, et al. Diff erence in Muscle Quality over the Adult Life Span and Biological Correlates in the Baltimore Longitudinal Study of Aging. J Am Geriatr Soc 2014;
21 Sakuma K, Yamaguchi A. Sarcopenic obesity and endocrinal adaptation with age. Int J Endocrinol 2013; 2013: 204164.
22 Chau D, Cho LM, Jani P, St Jeor ST. Individualizing  recommendations for weight management in the elderly. Curr Opin Clin Nutr Metab Care 2008; 11: 27–31.
23 Benton MJ, Whyte MD, Dyal BW. Sarcopenic obesity: strategies for management. Am J Nurs 2011; 111: 38–44, quiz 45–46.
24 Bartali B, Frongillo EA, Stipanuk MH, et al. Protein intake and muscle strength in older persons: does infl ammation matter? J Am Geriatr Soc 2012; 60: 480–84.
25 Larsson L. Morphological and functional characteristics of the ageing skeletal muscle in man. A cross-sectional study. Acta Physiol Scand Suppl 1978; 457: 1–36.
26 Larsson L, Li X, Frontera WR. Eff ects of aging on shortening velocity and myosin isoform composition in single human skeletal muscle cells. Am J Physiol 1997; 272: C638–49.
27 Dube J, Goodpaster BH. Assessment of intramuscular triglycerides: contribution to metabolic abnormalities. Curr Opin Clin Nutr Metab Care 2006; 9: 553–59.
28 Crane JD, Devries MC, Safdar A, Hamadeh MJ, Tarnopolsky MA. The eff ect of aging on human skeletal m uscle mitochondrial and intramyocellular lipid ultrastructure. J Gerontol A Biol Sci Med Sci 2010; 65: 119–28.
29 Verdijk LB, Gleeson BG, Jonkers RA, et al. Skeletal muscle hypertrophy following resistance training is accompanied by a fi ber type-specifi c increase in satellite cell content in elderly men.J Gerontol A Biol Sci Med Sci 2009; 64: 332–39.
30 Day K, Shefer G, Shearer A, Yablonka-Reuveni Z. The depletion of skeletal muscle satellite cells with age is concomitant with reduced
capacity of single progenitors to produce reserve progeny. Dev Biol 2010; 340: 330–43.
31 Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005; 433: 760–64.
32 Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006 Diabetes Care 2009; 32: 287–94.
33 Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4–14.
34 Kalyani RR, Saudek CD, Brancati FL, Selvin E. Association of diabetes, comorbidities, and A1C with functional disability in older
adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999-2006. Diabetes Care 2010; 33: 1055–60.
35 Volpato S, Bianchi L, Lauretani F, et al. Role of muscle mass and muscle quality in the association between diabetes and gait speed.
Diabetes Care 2012; 35: 1672–79.
36 Park SW, Goodpaster BH, Lee JS, et al, and the Health, Aging, and Body Composition Study. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care 2009; 32: 1993–97.
37 Park SW, Goodpaster BH, Strotmeyer ES, et al, and the Health, Aging, and Body Composition Study. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care 2007; 30: 1507–12.
38 Lee CG, Boyko EJ, Barrett-Connor E, et al, and the Osteoporotic Fractures in Men (MrOS) Study Research Group. Insulin sensitizers may attenuate lean  mass loss in older men with diabetes. Diabetes Care 2011; 34: 2381–86.
39 Kalyani RR, Tra Y, Yeh HC, Egan JM, Ferrucci L, Brancati FL.Quadriceps strength, quadriceps power, and gait speed in older U.S. adults with diabetes mellitus: results from the National Health and Nutrition Examination Survey, 1999–2002. J Am Geriatr Soc 2013;61: 769–75.
40 Barzilay JI, Cotsonis GA, Walston J, et al, and the Health ABC Study. Insulin resistance is associated with decreased quadriceps muscle strength in nondiabetic adults aged >or=70 years. Diabetes Care 2009; 32: 736–38.
41 Kuo CK, Lin LY, Yu YH, Wu KH, Kuo HK. Inverse association between insulin resistance and gait speed in nondiabetic older men: results from the U.S. National Health and Nutrition Examination Survey (NHANES) 1999–2002. BMC Geriatr 2009; 9: 49.
42 Bandeen-Roche K, Xue QL, Ferrucci L, et al. Phenotype of frailty: characterization in the women’s health and aging studies.J Gerontol A Biol ci Med Sci 2006; 61: 262–66.
43 Fried LP, Tangen CM, Walston J, et al, and the Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146–56.
44 Kalyani RR, Tian J, Xue QL, et al. Hyperglycemia and incidence of frailty and lower extremity mobility limitations in older women. J Am Geriatr Soc 2012; 60: 1701–07.
45 Fujita S, Glynn EL, Timmerman KL, Rasmussen BB, Volpi E. Supraphysiological hyperinsulinaemia is necessary to stimulate skeletal muscle protein anabolism in older adults: evidence of a true age-related insulin resistance of muscle protein metabolism. Diabetologia 2009; 52: 1889–98.
46 Kaushik S, Singh R, Cuervo AM. Autophagic pathways and metabolic stress. Diabetes Obes Metab 2010; 12 (suppl 2): 4–14.
47 Wang X, Hu Z, Hu J, Du J, Mitch WE. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 2006; 147: 4160–68.
48 Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes.Diabetes 2002; 51: 2944–50.
49 Jerusalem F, Engel AG, Peterson HA. Human muscle fi ber fi ne structure: morphometric data on controls. Neurology 1975; 25: 127–34.
50 Mogensen M, Sahlin K, Fernstrom M, et al. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2007; 56: 1592–99.
51 Phielix E, Mensink M. Type 2 diabetes mellitus and skeletal muscle metabolic function. Physiol Behav 2008; 94: 252–58.
52 Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS. Eff ect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci USA 2003; 100: 7996–8001.
53 Sandri M, Lin J, Handschin C, et al. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specifi c gene transcription. Proc Natl Acad Sci USA 2006; 103: 16260–65.
54 Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, Dela F. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 2007; 50: 790–96.
55 Patti ME, Butte AJ, Crunkhorn S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 2003; 100: 8466–71.
56 Lira VA, Benton CR, Yan Z, Bonen A. PGC-1alpha regulation by exercise training and its infl uences on muscle function and insulin sensitivity. Am J Physiol Endocrinol Metab 2010;299: E145–61.
57 Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, et al. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 2007; 50: 113–20.
58 Waters DL, Baumgartner RN. Sarcopenia and obesity. Clin Geriatr Med 2011; 27: 401–21.
59 Ritz P. Editorial: Obesity in the elderly: should we be using new diagnostic criteria? J Nutr Health Aging 2009; 13: 168–69.
60 Janssen I, Mark AE. Elevated body mass index and mortality risk in the elderly. Obes Rev 2007; 8: 41–59.
61 Russo CR, Ricca M, Ferrucci L. True osteoporosis and frailty-related osteopenia: two diff erent clinical entities. J Am Geriatr Soc 2000;48: 1738–39.
62 Alley DE, Chang VW. The changing relationship of obesity and disability, 1988–2004. JAMA 2007; 298: 2020–27.
63 Tuttle LJ, Sinacore DR, Mueller MJ. Intermuscular adipose tissue is muscle specifi c and associated with poor functional performance. J Aging Res 2012; 2012: 172957.
64 Pedersen BK. The diseasome of physical inactivity--and the role of myokines in muscle-fat cross talk. J Physiol 2009; 587: 5559–68.
65 Newman AB, Lee JS, Visser M, et al. Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study. Am J Clin Nutr 2005; 82: 872–78, quiz 915–16.
66 Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci 2000; 904: 437–48.
67 Davison KK, Ford ES, Cogswell ME, Dietz WH. Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III. J Am Geriatr Soc 2002; 50: 1802–09.
68 Kohara K. Sarcopenic obesity in aging population: current status and future directions for research. Endocrine 2014; 45: 15–25.
69 Batsis JA, Barre LK, Mackenzie TA, Pratt SI, Lopez-Jimenez F, Bartels SJ. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with diff erent research defi nitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999–2004. J Am Geriatr Soc 2013; 61: 974–80.
70 Stenholm S, Alley D, Bandinelli S, et al. The eff ect of obesity combined with low muscle strength on decline in mobility in older persons: results from the InCHIANTI study. Int J Obes (Lond) 2009; 33: 635–44.
71 Bouchard DR, Dionne IJ, Brochu M. Sarcopenic/obesity and physical capacity in older men and women: data from the Nutrition as a Determinant of Successful Aging (NuAge)-the Quebec longitudinal Study. Obesity (Silver Spring) 2009; 17: 2082–88.
72 Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 2004; 12: 1995–2004.
73 Nilsson MI, Dobson JP, Greene NP, et al. Abnormal protein turnover and anabolic resistance to exercise in sarcopenic obesity. FASEB J 2013; 27: 3905–16.
74 Tchkonia T, Morbeck DE, Von Zglinicki T, et al. Fat tissue, aging, and cellular senescence. Aging Cell 2010; 9: 667–84.
75 Anderson EJ, Lustig ME, Boyle KE, et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 2009; 119: 573–81.
76 Sparks LM, Xie H, Koza RA, et al. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 2005; 54: 1926–33.
77 Maggio M, Ceda GP, Lauretani F, et al. Gonadal status and physical performance in older men. Aging Male 2011; 14: 42–47.
78 Labrie F, Belanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997; 82: 2396–402.
79 Boxer RS, Kenny AM, Dowsett R, Taxel P. The eff ect of 6 months of androgen deprivation therapy on muscle and fat mass in older men with localized prostate cancer. Aging Male 2005; 8: 207–12.
80 Bhasin S, Storer TW, Berman N, et al. The eff ects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996; 335: 1–7.
81 Krasnoff JB, Basaria S, Pencina MJ, et al. Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Off spring Study. J Clin Endocrinol Metab 2010; 95: 2790–99.
82 Travison TG, Basaria S, Storer TW, et al. Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. J Gerontol A Biol Sci Med Sci 2011; 66: 1090–99.
83 Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, et al. Eff ect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA 2008; 299: 39–52.
84 Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med 2010;363: 109–22.
85 Kadi F. Cellular and molecular mechanisms responsible for the action of testosterone on human skeletal muscle. A basis for illegal performance enhancement. Br J Pharmacol 2008; 154: 522–28.
86 Bondanelli M, Ambrosio MR, Margutti A, Franceschetti P, Zatelli MC, degli Uberti EC. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone. Neuroendocrinology 2003; 77: 380–87.
87 Giannoulis MG, Sonksen PH, Umpleby M, et al. The eff ects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab 2006;91: 477–84.
88 Schroeder ET, He J, Yarasheski KE, et al. Value of measuring muscle performance to assess changes in lean mass with testosterone and growth hormone supplementation. Eur J Appl Physiol 2012; 112: 1123–31.
89 Mudali S, Dobs AS. Eff ects of testosterone on body composition of the aging male. Mech Ageing Dev 2004; 125: 297–304. 9
0 Chahal HS, Drake WM. The endocrine system and ageing. J Pathol 2007; 211: 173–80.
91 McIntire KL, Hoff man AR. The endocrine system and sarcopenia: potential therapeutic benefi ts. Curr Aging Sci 2011; 4: 298–305.
92 Ryall JG, Schertzer JD, Lynch GS. Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology 2008; 9: 213–28.
93 Perrini S, Laviola L, Carreira MC, Cignarelli A, Natalicchio A, Giorgino F. The GH/IGF1 axis and sign aling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol 2010; 205: 201–10.
94 Nass R, Thorner MO. Impact of the GH-cortisol ratio on the age-dependent changes in body composition. Growth Horm IGF Res 2002; 12: 147–61.
95 Salomon F, Cuneo RC, Hesp R, Sonksen PH. The eff ects of treatment with recombinant human growth hormone on bod  composition and metabolism in adults with growth hormone defi ciency. N Engl J Med 1989; 321: 1797–803.
96 Liu H, Bravata DM, Olkin I, et al. Systematic review: the safety and effi cacy of growth hormone in the healthy elderly. Ann Intern Med 2007; 146: 104–15.
97 Riis AL, Jorgensen JO, Gjedde S, et al. Whole body and forearm substrate metabolism in hyperthyroidism: evidence of increased basal muscle protein breakdown. Am J Physiol Endocrinol Metab 2005; 288: E1067–73.
98 Norrelund H, Hove KY, Brems-Dalgaard E, et al. Muscle mass and function in thyrotoxic patients before and during medical treatment. Clin Endocrinol (Oxf) 1999; 51: 693–99.
99 Schakman O, Gilson H, Thissen JP. Mechanisms of glucocorticoid-induced myopathy. J Endocrinol 2008; 197: 1–10.
100 Gupta A, Gupta Y. Glucocorticoid-induced myopathy: pathophysiology, diagnosis, and treatment. Indian J Endocrinol Metab 2013; 17: 913–16.
101 Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int 2002; 13: 187–94.
102 Kalyani RR, Stein B, Valiyil R, Manno R, Maynard JW, Crews DC. Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis. J Am Geriatr Soc 2010;58: 1299–310.
103 Ferrucci L, Baroni M, Ranchelli A, et al. Interaction between bone and muscle in older persons with mobility limitations. Curr Pharm Des 2013;
104 Terracciano C, Celi M, Lecce D, et al. Diff erential features of muscle fi ber atrophy in osteoporosis and osteoarthritis. Osteoporos Int 2013;24: 1095–100.
105 Rolland Y, Abellan van Kan G, Gillette-Guyonnet S, Vellas B. Cachexia versus sarcopenia. Curr Opin Clin Nutr Metab Care 2011; 14: 15–21.
106 de Oliveira Nunes Teixeira V, Filippin LI, Viacava PR, de Oliveira PG, Xavier RM. Muscle wasting in collagen-induced arthritis and disuse atrophy. Exp Biol Med (Maywood) 2013; 238: 1421–30.
107 McDermott MM, Guralnik JM, Albay M, Bandinelli S, Miniati B, Ferrucci L. Impairments of muscles and nerves associated with peripheral arterial disease and their relationship with lower extremity functioning: the InCHIANTI Study. J Am Geriatr Soc 2004; 52: 405–10.
108 Abbatecola AM, Chiodini P, Gallo C, et al, and the Health ABC study. Pulse wave velocity is associated with muscle mass decline:Health ABC study. Age (Dordr) 2012; 34: 469–78.
109 Buford TW, Anton SD, Judge AR, et al. Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy. Ageing Res Rev 2010; 9: 369–83.
110 Lecker SH, Goldberg AL, Mitch WE. Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 2006; 17: 1807–19.
111 Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab 2004; 287: E591–601.
112 Taskapan H, Baysal O, Karahan D, Durmus B, Altay Z, Ulutas O. Vitamin D and muscle strength, functional ability and balance in peritoneal dialysis patients with vitamin D defi ciency. Clin Nephrol 2011; 76: 110–16.
113 Tessari P. Protein metabolism in liver cirrhosis: from albumin to muscle myofi brils. Curr Opin Clin Nutr Metab Care 2003; 6: 79–85.
114 Jones JC, Coombes JS, Macdonald GA. Exercise capacity and muscle strength in patients with cirrhosis. Liver Transpl 2012;18: 146–51.
115 Dodson S, Baracos VE, Jatoi A, et al. Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med 2011; 62: 265–79.
116 Muscaritoli M, Anker SD, Argiles J, et al. Consensus defi nition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 2010; 29: 154–59.
117 Stene GB, Helbostad JL, Balstad TR, Riphagen II, Kaasa S, Oldervoll LM. Eff ect of physical exercise on muscle mass and strength in cancer patients during treatment—a systematic review. Crit Rev Oncol Hematol 2013; 88: 573–93.
118 Grinspoon S, Corcoran C, Lee K, et al. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodefi ciency syndrome and wasting. J Clin Endocrinol Metab 1996; 81: 4051–58.
119 Souza PM, Jacob-Filho W, Santarem JM, Zomignan AA, Burattini MN. Eff ect of progressive resistance exercise on strength evolution of elderly patients living with HIV compared to healthy controls. Clinics (Sao Paulo) 2011; 66: 261–66.
120 Porro LJ, Herndon DN, Rodriguez NA, et al. Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and effi cacy. J Am Coll Surg 2012; 214: 489–502, discussion 502–04.
121 Cauza E, Strehblow C, Metz-Schimmerl S, et al. Eff ects of progressive strength training on muscle mass in type 2 diabetes mellitus patients determined by computed tomography. Wien Med Wochenschr 2009; 159: 141–47.
122 Davidson LE, Hudson R, Kilpatrick K, et al. Eff ects of exercise modality on insulin resistance and functional limitation in older adults: a randomized controlled trial. Arch Intern Med 2009;169: 122–31.
123 Fiatarone MA, O’Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994; 330: 1769–75.
124 Marzetti E, Calvani R, Cesari M, et al. Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int J Biochem Cell Biol 2013; 45: 2288–301.
125 Villareal DT, Banks M, Sinacore DR, Siener C, Klein S. Eff ect of weight loss and exercise on frailty in obese older adults. Arch Intern Med 2006; 166: 860–66.
126 Hikida RS, Staron RS, Hagerman FC, et al. Eff ects of high-intensity resistance training on untrained older men. II. Muscle fi ber characteristics and nucleo-cytoplasmic relationships. J Gerontol A Biol Sci Med Sci 2000; 55: B347–54.
127 Kosek DJ, Kim JS, Petrella JK, Cross JM, Bamman MM. Effi cacy of 3 days/wk resistance training on myofi ber hypertrophy and myogenic mechanisms in young vs. older adults. J Appl Physiol (1985) 2006; 101: 531–44.
128 Kryger AI, Andersen JL. Resistance training in the oldest old: consequences for muscle strength, fi ber types, fi ber size, and MHC isoforms. Scand J Med Sci Sports 2007; 17: 422–30.
129 Thornell LE. Sarcopenic obesity: satellite cells in the aging muscle. Curr Opin Clin Nutr Metab Care 2011; 14: 22–27.
130 Boule NG, Haddad E, Kenny  GP, Wells GA, Sigal RJ. Eff ects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 2001; 286: 1218–27.
131 Wycherley TP, Noakes M, Clifton PM, Cleanthous X, Keogh JB, Brinkworth GD. A high-protein diet with resistance exercise training improves weight loss and body composition in overweight and obese patients with type 2 diabetes. Diabetes Care 2010;33: 969–76.
132 Frosig C, Richter EA. Improved insulin sensitivity after exercise: focus on insulin signaling. Obesity (Silver Spring) 2009; 17 (suppl 3): 15–20.
133 Lund S, Holman GD, Schmitz O, Pedersen O. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA 1995; 92: 5817–21.
134 Tipton KD, Rasmussen BB, Miller SL, et al. Timing of amino acid-carbohydrate ingestion alters anabolic response of muscle to resistance exercise. Am J Physiol Endocrinol Metab 2001;281: E197–206.
135 Solerte SB, Gazzaruso C, Bonacasa R, et al. Nutritional supplements with oral amino acid  mixtures increases whole-body lean mass and insulin sensitivity in e derly subjects with sarcopenia. Am J Cardiol 2008; 101: 69E–77E.
136 Mazzali G, Di Francesco V, Zoico E, et al. Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: eff ect of moderate weight loss in older women. Am J Clin Nutr 2006; 84: 1193–99.
137 Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care 2009; 12: 86–90.
138 Symons TB, Schutzler SE, Cocke TL, Chinkes DL, Wolfe RR, Paddon-Jones D. Aging does not impair the anabolic response to a protein-rich meal. Am J Clin Nutr 2007; 86: 451–56.
139 Marsh AP, Lovato LC, Glynn NW, et al, and the LIFE Study Research Group. Lifestyle interventions and independence for elders study: recruitment and baseline characteristics. J Gerontol A Biol Sci Med Sci 2013; 68: 1549–58.



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024